Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Outlook on the Home Infusion Therapy Global Market to 2028 - Featuring Fresenius Kabi, JMS, PharmaScript, CareCentrix and PromptCare Among Others

Research and Markets Logo

News provided by

Research and Markets

Mar 01, 2023, 12:00 ET

Share this article

Share toX

Share this article

Share toX

DUBLIN, March 1, 2023 /PRNewswire/ -- The "Global Home Infusion Therapy Market (By Product, Application, Region), Impact of COVID-19, Key Company Profiles, Trends and Recent Developments - Forecast to 2028" report has been added to  ResearchAndMarkets.com's offering.

This report provides a comprehensive analysis of the global home infusion therapy market, the global home infusion therapy market is predicted to reach US$ 53.2 Billion by 2028.

Companies Mentioned

  • B. Braun Melsungen AG
  • Eli Lilly
  • Becton, Dickinson and Company
  • Baxter International Inc.
  • Smiths Medical (Now Part of ICU Medical)
  • Terumo Corporation
  • ICU Medical
  • CVS/Coram
  • Option Care Health
  • BriovaRx / OptumRx/ Diplomat (UnitedHealth Group)
  • PharMerica
  • Fresenius Kabi
  • JMS Co. Ltd.
  • PharmaScript
  • CareCentrix, Inc.
  • PromptCare
  • Infusystem
  • AIS Healthcare
  • Altus Biologics
  • ContinuumRX
  • FlexCare Infusion Centers
  • Healix
  • KabaFusion
  • InfuCare Rx
  • Palmetto Infusion

Home infusion therapy is a process of subcutaneous or intravenous administration of biologicals or drugs to a person at home.

Home infusion therapy offers various benefits such as cost-effective, convenient, offer better outcomes, and have higher safety standards. Various government programs are being implemented to shift patients towards home care and reduce the overall hospitalization and treatment costs.

Additionally, the rise in preference for homecare among patients, particularly for infusion treatment, and the growing developments in infusion healing devices designed for home usage are some of the key factors anticipated to fuel the market growth. Moreover, the growing geriatric population and increasing prevalence of cancer, Crohn's disease, multiple sclerosis, nutritional and immune deficiencies, dehydration, and nausea & vomiting are major factors driving the market growth.

Many home infusion service providers, such as Option Care Health Inc., are working in collaboration with hospitals to facilitate the shift of patients at home care settings to receive treatment, thus driving market growth.

Impact of COVID-19 on Global Home Infusion Therapy Market

The COVID-19 outbreak has become a global stress test. As the number of people infected with the virus continues to rise around the world, uncertainties about global economic growth increases. The COVID-19 disease has infected over 627 million people worldwide. Globally the death toll has reached 6,562,012 according to the latest statistics from the Worldometers. The number is still growing, and the duration of the pandemic is still difficult to predict.

The COVID-19 pandemic had a positive impact on the home infusion therapy market. Major market players reported a notable growth in their revenues from home infusion therapy business segment as the number of patients receiving care from homecare settings surged amid stay-at-home orders.

For instance, in 2020, Option Care Health, Inc. saw over 30% rise in revenue due to increased demand for home infusion therapy services. Additionally, Arkansas-based Delta Medical Infusion witnessed 50% increase in their patient load for home infusion therapy services as compared to the previous year. Thus, the COVID-19 pandemic has increased the importance and demand for medical devices especially in a home-based setting as the virus is transmitted through physical contact.

Global Home Infusion Therapy Market - Recent Developments

  • In April 2022, CarepathRx, a US-based pharmacy, and medication management solutions, partnered with Mount Sinai Health System, a US-based hospital network. This partnership allows expanding patient access to home infusion therapies across the Mount Sinai Health System, encompassing its eight hospitals and ambulatory footprint.
  • In May 2021, Smiths Medical and Ivenix, Inc. announced a partnership to deliver a comprehensive range of infusion management solutions to the U.S. market. The goal of this partnership is to enhance infusion administration and patient safety.
  • In January 2021, Amedisys collaborated with Option Care Health to deliver COVID-19 infusion therapy to the Vulnerable population.
  • In March 2020, KabaFusion, a leading provider of specialty acute and chronic home infusion therapies, announced that it has acquired the home infusion assets of Lincare, a subsidiary of Linde plc.

By Product - Global Home Infusion Therapy Market and Forecast

Based on product, the home infusion therapy market is segmented into infusion pumps, intravenous sets, IV cannulas, and needleless connectors. In 2021, Infusion pumps dominated the market with over 50% share of the total market. This can be attributed to their increasing use and efficiency in delivering nutrition, medications, and other required fluids into a patient's body in a controlled manner.

Nowadays, smart pumps are widely used as these pumps contain advanced features such as barcode technology, which helps in the verification of a patient's identity and prevents drug administration errors.

Needleless connectors is expected to be the fastest-growing segment over the forecast period owing to various benefits, such as less risk of bacterial contamination and higher protection against needlestick injuries. These connectors offer improved safety, enable smooth surgeries, and help adhere to good clinical practice (GCP), which contributes to the growth of the segment.

By Application - Global Home Infusion Therapy Market and Forecast

Based on application, the anti-infective segment held over a quarter of the market in 2021 impelled by the benefits provided by the anti-infective infusion therapy treatment. This intravenous infusion of antifungal, antiviral, or antibiotic drugs is highly used to treat infections that do not respond to oral therapeutics, thereby significantly driving the industry value.

The enteral nutrition segment accounted for second highest share of the total home infusion therapy market in 2021. The enteral nutrition should be used in patients who cannot meet their nutrient requirements by oral intake, yet have a functional gastrointestinal (GI) tract, and who are able to receive therapy outside of an acute care setting.

It is estimated that around 400,000 people of all ages in the US are receiving enteral nutrition at home. Chemotherapy is the fastest growing application for home infusion therapy market. With the growing incidences of cancer, the demand for pressure pumps is expected to increase in the coming years. Pumps used for chemotherapy at home are compact, continuous pressure pumps that do not require a battery and can hence be used for a longer period of time.

By Region - Global Home Infusion Therapy Market and Forecast

On a regional basis, North America dominates the home infusion therapy market in 2021 and this trend is expected to continue throughout the forecast period. Europe is projected to gain substantial growth due to the increasing burden of chronic diseases and the expanding geriatric population. Additionally, growing government initiatives are expected to fuel the growth of the regional home infusion therapy market. Asia Pacific is expected to register the fastest growth over the forecast period. This is attributed to rising patient awareness regarding the benefits of home infusion therapy over in-hospital procedures and the growing prevalence of diabetes in the region.

Key Topics Covered:

1. Executive Summary

2. Impact of COVID-19 on Home Infusion Therapy Market

3. Global - Home Infusion Therapy Market and Forecast (2015 - 2028)

4. Global - Home Infusion Therapy Market Share and Forecast (2015 - 2028)
4.1 By Product - Global Home Infusion Therapy Market Share and Forecast
4.2 By Application - Global Home Infusion Therapy Market Share and Forecast
4.3 By Region - Global Home Infusion Therapy Market Share and Forecast

5. By Product - Global Home Infusion Therapy Market and Forecast (2015 - 2028)
5.1 Global Home Infusion Therapy - Infusion Pump Market and Forecast
5.2 Global Home Infusion Therapy - Intravenous Sets Market and Forecast
5.3 Global Home Infusion Therapy - IV Cannulas Market and Forecast
5.4 Global Home Infusion Therapy - Needleless Connectors Market and Forecast

6. By Application - Global Home Infusion Therapy Market and Forecast (2015 - 2028)
6.1 Global Home Infusion Therapy - Anti-infective Market and Forecast
6.2 Global Home Infusion Therapy - Enteral Nutrition Market and Forecast
6.3 Global Home Infusion Therapy - Parenteral Nutrition Market and Forecast
6.4 Global Home Infusion Therapy - Specialty Pharmaceuticals Market and Forecast
6.5 Global Home Infusion Therapy - Chemotherapy Market and Forecast
6.6 Global Home Infusion Therapy - Hydration Therapy Market and Forecast
6.7 Global Home Infusion Therapy - Others Market and Forecast

7. By Region - Global Home Infusion Therapy Market and Forecast (2015 - 2028)
7.1 North America - Home Infusion Therapy Market and Forecast
7.2 Europe - Home Infusion Therapy Market and Forecast
7.3 Asia Pacific - Home Infusion Therapy Market and Forecast
7.4 Latin America - Home Infusion Therapy Market and Forecast
7.5 Middle East and Africa - Home Infusion Therapy Market and Forecast

8. Global Home Infusion Therapy Market - Recent Developments

9. Global Home Infusion Therapy Market - Driving Factors
9.1 Increasing Geriatric Population
9.2 Rising Prevalence of Chronic Diseases
9.3 Increasing Incidence of Hospital-Acquired Infections
9.4 Improving Healthcare Infrastructure in Emerging Economies
9.5 Technological Advancements

10. Global Home Infusion Therapy Market - Challenges
10.1 Perceived Safety Concerns
10.2 Complicated Reimbursement Framework

11. Global Home Infusion Therapy Market - Key Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/783git-home?w=5

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.